Home/Pipeline/Real-Time Ablation Guidance Software

Real-Time Ablation Guidance Software

Solid Tumors (e.g., Lung Cancer)

Clinical TrialActive

Key Facts

Indication
Solid Tumors (e.g., Lung Cancer)
Phase
Clinical Trial
Status
Active
Company

About NE Scientific

NE Scientific is a pioneer in real-time simulation software for percutaneous ablation, a minimally invasive cancer treatment. The company addresses a critical clinical gap where 10-30% of procedures leave untreated tumor tissue due to a lack of intraoperative guidance, leading to recurrence. Its core technology uses GPU acceleration to model ablation physics (RFA, MWA, Cryo, etc.) in real-time, overlaying the predicted treatment zone on live imaging to guide physicians. Backed by over $1.8M in NCI SBIR grants and industry awards from Johnson & Johnson and NVIDIA, NE Scientific has progressed its technology into clinical trials.

View full company profile

Therapeutic Areas

Other Solid Tumors (e.g., Lung Cancer) Drugs

DrugCompanyPhase
ARAC-02 (ARAC™)Pdx PharmaceuticalsPreclinical